𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dose proportionality of nadolol pharmacokinetics after intravenous administration to healthy subjects

✍ Scribed by R. A. Morrison; S. M. Singhvi; W. A. Creasey; D. A. Willard

Publisher
Springer
Year
1988
Tongue
English
Weight
397 KB
Volume
33
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pharmacokinetics of ketotiffn after oral
Pharmacokinetics of ketotiffn after oral administration to healthy male subjects
✍ Dr A. GrahnΓ©n; A. LΓΆnnebo; O. Beck; S-Γ… EckernΓ€s; B. DahlstrΓΆm; B. LindstrΓΆm πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 406 KB πŸ‘ 2 views

## Abstract The pharmacokinetics of 2 mg ketotifen from four different oral dosage forms were examined in two randomized, balanced cross‐over studies. Forty healthy male subjects participated. Each of 20 subjects received two capsule formulations and each of the other 20 subjects received two syrup

Pharmacokinetics and dose proportionalit
Pharmacokinetics and dose proportionality of BMS-204352 after intraarterial administration to rats
✍ Rajesh Krishna; Vinod R. Shah; Nuggehally Srinivas πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 73 KB πŸ‘ 1 views

BMS-204352 is a novel maxi-K channel opener that is being developed for the treatment for stroke. The current study was designed to evaluate the dose proportionality and pharmacokinetics of BMS-204352 in rats. In an open, parallel fashion, sixteen rats per gender received a single intraarterial dose

Clinical pharmacokinetics of procaterol:
Clinical pharmacokinetics of procaterol: Dose proportionality after administration of single oral doses
✍ Dr Michael A. Eldon; Debbie S. Blake; Michael J. Coon; Gerald D. Nordblom; Allen πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 328 KB πŸ‘ 2 views

Procaterol is a potent, orally active &-agonist bronchodilator useful in the treatment of reversible bronchospastic disease. It is effective when administered as single or multiple (Q8H) 50 and 75pg doses. As part of the clinical development of procaterol, the pharmacokinetics and dose proportionali